Insulin Flashcards

1
Q

When do you used insulin treatment?

A

Insulin replacement in T1DM
- 30-50 units/day but this varies depending on weight, diet + activity. Long acting insulin (1 or 2 injections) + rapid or short acting insulin (injected with meals)

Control of blood glucose in T2DM when oral hypoglycaemic treatment is inadequate or poorly tolerated.

Diabetic emergencies (IV in diabetic ketoacidosis, hyperglycaemic hyperosmolar syndrome, perioperative glycaemic control) 
> IV fluids and K+ at a rate determine by blood glucose conc

Alongside glucose to treat hyperkalaemia while other measures are initiated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many phases of insulin release are there in response to constant glucose?

A

2

1st peak > rapid peak is release of ready-made insulin
2nd phase > slower release relies on synthesis of new insulin molecules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where is preproinsulin produced?

What happens to it then?

A

Rough endoplasmic reticulum
Processed in golgi system and its packed into vesicles.
Preproinsulin goes through proteolytic cleavage, chopped into proinsulin then insulin.
21+30 amino acid long chains/peptides linked together by disulfide bridges.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the role of K-ATP channel in initiating insulin release

A
  1. an increase in [glucose] leads to increased metabolic flux
  2. increased metabolic flux increases [ATP]/[ADP]
  3. Increased [ATP]/[ADP] closes K-ATP channels
  4. Plasma membrane depolarises
  5. Voltage-dependent Ca2+ channels open
  6. Ca2+ influx leads to increased intracellular [Ca2+]
  7. Ca2+ triggers insulin secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens to insulin after its secretion?

A

Insulin will bind to insulin receptors in insulin sensitive tissues like muscle, liver, adipose tissues.
Higher density of receptors = higher sensitivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What family do insulin receptors belong to?

A

Insulin receptors belong to tyrosine kinase linked receptor family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the structure of an insulin receptor

A

Insulin receptors have an extracellular ligand binding site for insulin.
Has 4 polypeptide chains linked by disulfide bridges.
Tyrosine kinase enzyme domain is inside cell. This enzyme can phosphorylate tyrosine residues on receptor + other proteins in cytosol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how does insulin regulate metabolism? (3)

A
  1. Promotes synthesis and storage of carbohydrates, lipids and proteins while inhibits their degradation and release into circulation.
  2. stimulates uptake of glucose, amino acids and fatty acids into cells.
  3. increases the expression and activity of enzymes that catalyse glycogen synthesis while inhibiting the activity or expression of those that catalyse degradation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe transduction in insulin action

A
  • Insulin receptor is a tyrosine kinase that undergoes autophosphorylation and catalyses the phosphorylation of cellular proteins (IRS family, Shc, CbI).
  • Upon tyrosine phosphorylation these proteins interact with signalling molecules through their SH2 domains resulting in the activation of diverse series of signalling pathways.

> immediate effect of stimulation of insulin receptors is that it will lead to insertion of glucose transporters into plasma membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GLUT-4
What are the major sites of expression?
What is its characteristics?

A
  1. Skeletal and cardiac muscle
  2. the insulin-responsive glucose transporter. high affinity for glucose.

GLUt 4 is translocated from intracellular compartments into plasma membrane. Influx of glucose into cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GLUT-2
What are its major sites?
What is its characteristics?

A
  1. Liver, pancreatic, beta cells, small intestine, kidney
  2. Transports glucose, galactose and fructose.
    A low affinity, high capacity glucose transporter; serves as a “glucose sensor” in pancreatic beta cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the metabolic effects of insulin in liver cells?

A
CARBOHYDRATE:
> Decrease gluconeogenesis
> Decrease glycogenolysis
> Increase glycolysis
> increase glycogenesis

FAT
> increase lipogenesis
> decrease lipolysis

PROTEIN
> decrease protein breakdown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What metabolic effect does insulin have in fat cells?

A

CARBOHYDRATE:
> glucose uptake
> glycerol synthesis

FAT
> incr triglyceride synthesis
> increase fatty acid synthesis
> decrease lipolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What metabolic effects does insulin have in muscle cells?

A

CARBOHYDRATE
> Incr glucose uptake
> incr glycolysis
> increase glycogenesis

PROTEIN
> increase amino acid uptake
> increase protein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is glyconeogenesis?

A

glucose synthesis from non carbohydrate molecules (aa, lactate, glycerol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is glycolysis?

A

anaerobic conversion of glucose to lactate or pyruvate and energy (ATP)

17
Q

What is glycogenesis?

A

glycogen synthesis from glucose

18
Q

What is glycogenolysis?

A

Glycogen breakdown to glucose

19
Q

What is lypogenesis?

A

Transformation of non-fat food materials into body fat

20
Q

What is lipolysis?

A

lipid breakdown

21
Q

What is the main action of insulin?
Main stimulus for secretion?
Main effect?

A

A) increase glucose uptake
increase glycogen synthesis (glycogenesis)
decrease glycogenolysis
decrease gluconeogenesis

b) moment-to-moment fluctuations in blood glucose
c) decrease blood glucose

22
Q

What are the main actions of glucagon?
Main stimulus for secretion?
Main effect?

A

Increased glycogenolysis
Hypoglycaemia (blood glucose <3mM)
Increase blood glucose

23
Q

What are the main actions of catecholamines?
Main stimulus for secretion?
Main effect?

A

a) increase glycogenolysis
decrease glucose uptake

b) hypoglycaemia (blood glucose <3 mM)
c) incr blood glucose

24
Q

What are the main actions of glucocorticoids?
Main stimulus for secretion?
Main effect?

A

a) increase gluconeogenesis
glucose uptake and utilisation

b) hypoglycaemia (blood glucose <3 mM)
c) incr blood glucose

25
Q

What are the main actions of Growth hormone?
Main stimulus for secretion?
Main effect?

A

a) Decrease glucose uptake
b) hypoglycaemia (blood glucose <3 mM)
c) incr blood glucose

26
Q

What are the differences in treatment for IDDM (type I) and NIDDM (type II)?

A

IDDM (type I)
- insulin & diet

NIDDM (type 2)

  • diet only
  • diet & oral hypoglycaemic agents (biguanides e.g. metformin. sulphonylureas e.g. tolbutamide)
  • diet & insulin (1/3 pts)
27
Q

How do you monitor treatment of diabetes?

A
  • Blood glucose measurement
  • Glycated haemoglobin (HbA1c) > reliable representation of the mean blood glucose over the previous 6-12 weeks. healthy: 4-6%. Diabetes >7% HbA1c)
  • Blood pressure
28
Q

What are the types of insulin preparations? (usually sc, but iv or im in emergencies)

A

Short acting (peak action: 2-4 hrs)
Intermediate (peak action: 6-12 hrs)
Long acting (peak action: 14-24hrs)
(these can be used in combination to achieve good control of blood glucose levels)

29
Q

What are insulin analogues?

A

insulin lispro (actos more rapidly but for a shorter time)

Insulin glargine (provides a constant basal level)

30
Q

What are the unwanted effects of insulin?

A
  • Hypoglycaemia

- Formation of anti-insulin antibodies causing insulin resistance

31
Q

How does insulin decrease blood glucose?

A

1) increasing glucose uptake into muscle and fat via GLUT4
2) increasing glycogen synthesis
3) decreasing gluconeogenesis
4) decreasing glycogen breakdown

32
Q

Glucagon is a fuel-mobilising hormone, stimulating: (4)

A

1) gluconeogenesis
2) glycogenolysis
3) lipolysis
4) proteolysis